Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.
about
Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's diseaseHigh-throughput 3D whole-brain quantitative histopathology in rodents.Current neuroimaging techniques in Alzheimer's disease and applications in animal modelsCerebral vascular leak in a mouse model of amyloid neuropathology.A review of β-amyloid neuroimaging in Alzheimer's disease.Mouse brain magnetic resonance microscopy: Applications in Alzheimer disease.Superparamagnetic nanoparticle-enhanced MRI of Alzheimer's disease plaques and activated microglia in 3X transgenic mouse brains: Contrast optimization.Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease.Fiber Tracts Anomalies in APPxPS1 Transgenic Mice Modeling Alzheimer's Disease.Fluid-attenuated inversion recovery hypointensity of the pulvinar nucleus of patients with Alzheimer disease: its possible association with iron accumulation as evidenced by the t2(*) mapSPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.In Vivo Detection of Amyloid Plaques by Gadolinium-Stained MRI Can Be Used to Demonstrate the Efficacy of an Anti-amyloid ImmunotherapyMRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice.Models of neurodegenerative disease - Alzheimer's anatomical and amyloid plaque imaging.Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues.Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease.In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by moleculaContrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer's disease brains.Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain.In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through?Metal complexes for multimodal imaging of misfolded protein-related diseases.Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects.
P2860
Q27309046-C21D271D-E178-489F-A938-7BB23558B870Q27349467-15349222-DA80-4EC8-A841-921F574FC4B8Q30576714-5AC544A2-DF7F-44FA-9126-7CC045D86D4EQ30609094-3A16DA89-68CE-4568-BB69-0ADEBCEEF1D1Q30870063-BC5D006E-BC85-40AF-9300-5F51CC1C51A4Q30916838-7184EF2D-0A9B-4BE0-B239-C82B739D2A02Q31144061-766A7071-1D6B-4470-A8B8-9966E156D838Q34658166-4C32254A-E7FF-4DF2-BEF4-82387D5CFCAFQ35207688-59A2D358-6DE1-490B-9DAF-09DC7DCD833BQ36357229-253C41D4-7539-4964-A9F7-96A37BDB82E5Q36710294-19FC1258-8F6A-4697-AEB4-DE49CD97060EQ36715449-9D8221D1-EC80-458B-BFB7-36D9B7AAE154Q37295234-EE71BE0F-C908-404C-9A70-890E705EC8C1Q37399746-6562137E-59F2-4250-9121-822582657C5CQ37771023-253A98B3-47A6-45F6-984A-B53B1A5D584DQ37866098-2E4EEDD5-4919-47C3-9E4F-38105A2B9DE0Q38447377-1C5F00D9-C0DB-4959-9C0A-F65C64F232D0Q41711189-6D0B94EA-D2CD-40E2-A2FC-EC501DF33056Q42084531-C2E64115-EEC8-4E33-9218-14BD7DEC3AD5Q42118376-1A576804-85E6-448B-813D-26D6E564D138Q47737459-3C1F57E5-5D45-4D15-9622-A27EE70337ADQ52567369-B53BAB21-DBE4-4F19-A81D-4A359DF58E6F
P2860
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.
@en
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.
@nl
type
label
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.
@en
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.
@nl
prefLabel
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.
@en
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.
@nl
P2093
P1476
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.
@en
P2093
Andreas Volk
Benoît Delatour
Carmen Quintana
Marc Dhenain
Maryvonne Guégan
Nadine El Tannir El Tayara
Ting-Di Wu
P356
10.1016/J.NEUROBIOLAGING.2007.05.018
P577
2007-06-27T00:00:00Z